Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$49,055,203
+$5,287,516 QoQ
Shares Held
194,942
-3.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#371
of 4,150 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOKF, NA holds $220,983,153 across 10 Drug Manufacturers - General names. ABBV ranks #2 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,087 | $61,275,284 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
194,942 | $49,055,203 | |
| 3 | JNJ |
Johnson & Johnson
|
142,681 | $36,236,693 | |
| 4 | AMGN |
Amgen Inc
|
67,477 | $24,434,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
136,461 | $17,240,482 | |
| 6 | MRK |
Merck & Co., Inc.
|
114,907 | $14,765,549 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
244,226 | $14,072,301 | |
| 8 | PFE |
Pfizer Inc
|
82,045 | $1,975,643 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,055,203 | 194,942 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $43,767,687 | 201,240 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $50,437,567 | 220,743 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $54,877,063 | 237,009 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $45,556,901 | 245,431 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $52,417,503 | 250,179 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $47,713,338 | 268,505 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $53,044,312 | 268,606 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,440,793 | 264,930 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $47,332,706 | 259,927 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $49,488,119 | 319,340 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $45,269,223 | 303,698 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $42,436,177 | 314,972 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $52,760,713 | 331,058 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $60,434,220 | 373,951 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $51,046,370 | 380,347 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $62,682,261 | 409,260 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $67,035,240 | 413,517 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $56,401,817 | 416,557 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $73,212,771 | 678,713 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $122,916,600 | 1,135,803 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $120,142,901 | 1,121,259 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $27,276,664 | 311,413 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $26,592,445 | 270,854 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $16,081,270 | 211,068 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||